12 Jan 2022 , 12:22 PM
Bliss GVS Pharma Limited’s credit rating has been revised by Infomerics Valuation and Rating Private Limited with respect to the bank facilities of the company.
The long-term bank facilities Rs84.25cr (increased from Rs70cr) in Exim Bank and Federal Bank have been revised to IVR BBB/ Stable from IVR BBB- / Positive.
The credit rating agency also revised the company’s rating on short-term bank facilities Rs75cr (reduced from Rs90cr) in Federal Bank to IVR A3+ from IVR A3.
At around 12.20 PM, Bliss GVS Pharma Ltd was trading at Rs99.40 per share down by Rs0.05 or 0.05% from its previous closing of Rs99.45 per share on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.